Aspire Pharma, a rapidly growing UK-based specialty generics business, has announced the acquisition of Charlwood Pharma, a ...

Following an extensive review, Belgian biotech Galapagos today revealed its intention to wind down its cell therapy business ...

German Merck KGaA’s recently acquired subsidiary SpringWorks Therapeutics today announced that long-term efficacy and safety data from the Phase III DeFi trial of Ogsiveo (nirogacestat) were in the ...

Oncolytic immunotherapies specialist Replimune Group has announced that the US Food and Drug Administration (FDA) has ...

South Korea-based Samsung Bioepis and Chinese biotech start-up Phrontline Biopharma have entered into a global collaboration ...

US trade group the Research and Manufacturers of America (PhRMA) has hailed the impact of direct purchase programs (DPPs), ...

California, USA-based Alto Neuroscience saw its shares shoot up more than 80% to $11.00 yesterday, after it revealed it has ...

US contract manufacturer Life Science Outsourcing has appointed Doug Constable as chief executive to steer its next growth ...

South Korea’s SK Biopharmaceuticals (KRX: 326030) has partnered with Brazil’s Eurofarma to launch Mentis Care, a ...

Five months after closing its Series B financing, USA-based NewLimit has raised an additional $45 million from Eli Lilly), ...

Swiss pharma giant Roche’s US subsidiary Genentech yesterday revealed that the US Food and Drug Administration (FDA) has ...

US biopharma firm Viridian Therapeutics has entered into a royalty financing agreement with DRI Healthcare Acquisitions (DRI) and accelerated its timelines for the submission of the veligrotug BLA and ...